Major Rectal Cancer Treatment Breakthrough
A groundbreaking cancer trial at Sloan Kettering of a new drug, dostarlimab, has shown unprecedented results: the cancer disappeared in 100% of the trial participants.
A groundbreaking cancer trial at Sloan Kettering of a new drug, dostarlimab, has shown unprecedented results: the cancer disappeared in 100% of the trial participants.
© 2025, National Cancer Center Inc. | All Rights Reserved
400 Montauk Highway
Suite 110
West Islip, NY 11795
National Cancer Center, Inc. is a 501(c)(3) organization. Gifts are deductible to the full extent allowable under IRS regulations.
Built by A Social Strategy
National Cancer Center has earned a 2024 Platinum Seal of Transparency from Guidestar, the world's largest source of information about nonprofit organizations. For more information about Guidestar, please click here
Support NCC when you shop at Paypal, eBay, and other online platforms through Paypal Giving Fund